Famars, France

Xavier Thomas

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 80(Granted Patents)


Location History:

  • Rhode-Saint-Genese, BE (2012)
  • Famars, FR (2014 - 2024)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Xavier Thomas

Introduction

Xavier Thomas is a notable inventor based in Famars, France. He has made significant contributions to the field of transdermal therapeutic systems, holding a total of nine patents. His work focuses on the transdermal administration of guanfacine, a medication used to treat various conditions.

Latest Patents

Among his latest patents, one includes a transdermal therapeutic system for the transdermal administration of guanfacine comprising at least one additive. This invention features a guanfacine-containing layer structure that includes a backing layer and a guanfacine-containing layer, utilizing at least one polymer and an additive. Another notable patent involves a similar transdermal therapeutic system, but specifically incorporates a silicone polymer in the guanfacine-containing layer structure.

Career Highlights

Throughout his career, Xavier Thomas has worked with prominent companies such as Dow Corning Corporation and LTS Lohmann Therapie-Systeme AG. His experience in these organizations has contributed to his expertise in developing innovative therapeutic systems.

Collaborations

Xavier has collaborated with several professionals in his field, including Linda Sue Nartker and Marco Emgenbroich. These collaborations have likely enhanced his research and development efforts.

Conclusion

Xavier Thomas is a distinguished inventor whose work in transdermal therapeutic systems has led to multiple patents and significant advancements in medication delivery. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…